An IVD test provides important information about diseases without interacting directly with the human body. IVD plays a major role in the early diagnosis and management of diseases.
IVD has applications in the diagnosis of infectious diseases, diabetes, oncology, cardiology, autoimmune diseases, nephrology, drug testing, HIV/AIDS and others. It is used by clinicians or physicians in hospitals, laboratories, other healthcare settings and at various stages of the patient care pathway.
Saudi Arabia In-Vitro Diagnostics Market-Market Dynamics
Saudi Arabia’s in-vitro diagnostics market is driven by a high demand for technologically advanced equipment for the early and precise diagnosis of diseases, the rise in population, and a rapid increase in the incidence of chronic and infectious diseases. However, the lack of proper reimbursement policies and the stringent regulatory framework are hindering the growth of the market.
The Saudi Arabian in-vitro diagnostics market can be segmented on the basis of technique: clinical chemistry, immunoassays, point of care diagnostics, molecular diagnostics, haematology, coagulation and microbiology; type of product: instruments, reagents and data management systems; usability: disposable IVD devices and reusable IVD devices; applications: infectious diseases, diabetes, oncology, cardiology, autoimmune diseases, nephrology, drug testing, HIV/AIDS and others; and end-user: laboratory, academics, hospitals, point of care testing and others.
Major Companies in the Sector Include:
Market analysis for Saudi Arabia’s In-Vitro Diagnostics (IVD) market, with region-specific assessments and competition analysis on the global and regional scale.
Market definition along with the identification of key drivers and restraints.
Identification of factors instrumental in changing the market scenario, rising prospective opportunities, and identification of key companies that can influence this market on a global and regional scale.
Extensively researched competitive landscape section with profiles of major companies along with their market share.
Identification and analysis of the macro and micro factors that affect Saudi Arabia’s IVD market on both global and regional scale.
A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information.
A wide-ranging knowledge and insights about the major players in this industry and the key strategies adopted by them to sustain and grow in the studied market.
Insights on the major countries/regions in which this industry is growing and to also identify the regions that are still untapped.
1.1 Study Deliverables
1.2 Market Definition
1.3 Sizing Units
1.4 Base Currency
1.5 Review and Forecast Period Years
1.6 General Study Assumptions
2. Research Methodology
2.2 Analysis Methodology
2.3 Econometric Forecast Model
2.4 Research Assumptions
3. Executive Summary
4. Key Inferences
5. Market Characterization
5.1 Current Market Scenario
5.2 Market Overview
5.3 Drivers, Restraints, Opportunities, and Challenges (DROC) Analysis
5.3.1 Market Drivers
188.8.131.52 Ageing Demographic
184.108.40.206 Rise in Chronic Wounds and Ulcers
220.127.116.11 Increase in Diabetes and Obese Population
18.104.22.168 Government Initiative on Injury Prevention
22.214.171.124 Increase in Number of Surgeries
5.3.2 Market Restraints
126.96.36.199 Lack of Reimbursement Policies
188.8.131.52 Lack of Awareness of Good Quality Care
5.3.3 Market Challenges
184.108.40.206 Pricing Pressures
5.3.4 Market Opportunities
220.127.116.11 Increasing Prevalence of Chronic Wounds
5.4 Woundcare Market Segmentation
5.4.1 By Product
18.104.22.168 Traditional Woundcare Products
22.214.171.124 Wound Dressings
126.96.36.199 Negative Pressure Wound Therapy
188.8.131.52 Wound Closure Diseases
184.108.40.206 Compression Therapy
5.4.2 By End-User
6. Industry Analysis
6.1 Key Trends and Developments
6.2 Investment Analysis
6.3 Porter’s Five Forces
6.3.1 Bargaining Power of Suppliers
6.3.2 Bargaining Power of Consumers
6.3.3 Threat of New Entrants
6.3.4 Threat of Substitute Products and Services
6.3.5 Competitive Rivalry within the Industry
7. Competitive Landscape
7.1 Key Market Players
7.1.1 Philips Healthcare
220.127.116.11 Philips Healthcare - Business Overview
18.104.22.168 Philips Healthcare - Product and Services Portfolio
22.214.171.124 Philips Healthcare - Deals Landscape
126.96.36.199 Philips Healthcare - SWOT Analysis
7.1.3 AGFA HealthCare
7.1.4 Siemens Healthcare
7.1.5 Shimadzu Corporation
7.1.6 Toshiba Medical Systems
7.2 Merger and Acquisition Analysis
7.3 New Product Launches
7.4 Agreements, Collaborations & Partnerships
8. Analyst Outlook for Investment Opportunities
9. Future Outlook of the Market